UK markets closed

Sangamo Therapeutics, Inc. (SGMO)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
0.4958-0.0202 (-3.94%)
As of 03:39PM EDT. Market open.
Currency in USD
Earnings estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts8888
Avg. Estimate-0.21-0.14-0.5-0.27
Low estimate-0.27-0.21-0.77-0.64
High estimate-0.1-0.08-0.230.28
Year ago EPS0.12-0.66-1.48-0.5
Revenue estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts6678
Avg. Estimate6.65M8.24M45.88M79.01M
Low estimate2M2M13.8M26.4M
High estimate11.3M17.8M95M229M
Year ago sales157.96M14.83M176.23M45.88M
Sales growth (year/est)-95.80%-44.40%-74.00%72.20%
Earnings history30/03/202329/06/202329/09/202330/12/2023
Est. EPS-0.33-0.34-0.32-0.26
Actual EPS0.12-0.66-0.59-0.34
Difference0.45-0.32-0.27-0.08
Surprise %136.40%-94.10%-84.40%-30.80%
EPS trendCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Current estimate-0.21-0.14-0.5-0.27
7 days ago-0.21-0.14-0.5-0.27
30 days ago-0.19-0.13-0.53-0.31
60 days ago-0.11-0.1-0.48-0.48
90 days ago-0.11-0.1-0.48-0.48
EPS revisionsCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/A1
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesSGMOIndustrySector(s)S&P 500
Current qtr.-275.00%N/AN/AN/A
Next qtr.78.80%N/AN/AN/A
Current year66.20%N/AN/AN/A
Next year46.00%N/AN/AN/A
Next 5 years (per annum)-17.90%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A